Skip to content

Clinical trials

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Not applicable Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20061
20071
20081
20092
20111
20151
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
Case Comprehensive Cancer Center2
Astex Pharmaceuticals, Inc.1
City of Hope Medical Center1
Eastern Cooperative Oncology Group1
M.D. Anderson Cancer Center1
Mayo Clinic1
Roswell Park Cancer Institute1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma15
Leukemia, Lymphocytic, Chronic, B-Cell15
Lymphoma, B-Cell, Marginal Zone15
Lymphoma, Follicular15
Lymphoma, Large B-Cell, Diffuse15
Lymphoma, Mantle-Cell15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma15
Lymphoma, Large-Cell, Immunoblastic14
Lymphoma, Non-Hodgkin14
Precursor Cell Lymphoblastic Leukemia-Lymphoma14

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.